Skip to Main content Skip to Navigation
Journal articles

Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization

Abstract : Heparanase is an endo-β-D-glucuronidase that plays an important role in cancer progression, in particular during tumor angiogenesis and metastasis. Inhibiting this enzyme is considered as one of the most promising approaches in cancer therapy. Heparin is a complex glycoaminoglycan known as a strong inhibitor of heparanase. It is primarily used in clinical practice for its anticoagulant activities, which may not be compatible with its use as anti-angiogenic agent. In this study, we described the production of ultra-low-molecular-weight heparins (ULMWH) by a physicochemical method that consists in a hydrogen peroxide-catalyzed radical hydrolysis assisted by ultrasonic waves. We assessed the structural characteristics, anticoagulant and anti-heparanase activities of the obtained heparin derivatives and compared them with three commercial low-molecular-weight heparins (LMWH), glycol-split non-anticoagulant heparins and heparins produced by enzymatic methods. ULMWH generated by the physicochemical method were characterized by high anti-heparanase and moderate anticoagulant activities. These heparin derivatives might be potential candidates for cancer therapy when a compromise is needed between anti-heparanase and anticoagulant activities.
Document type :
Journal articles
Complete list of metadata
Contributor : Viviane Biou <>
Submitted on : Friday, January 27, 2017 - 12:01:43 PM
Last modification on : Friday, December 11, 2020 - 6:04:04 PM




Oussama Achour, Nicolas Poupard, Nicolas Bridiau, Stéphanie Bordenave-Juchereau, Frédéric Sannier, et al.. Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization. Carbohydrate Polymers, Elsevier, 2016, ⟨10.1016/j.carbpol.2015.08.041⟩. ⟨hal-01447822⟩



Record views